These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 15535431)
41. Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes. Deacon CF; Holst JJ Int J Biochem Cell Biol; 2006; 38(5-6):831-44. PubMed ID: 16242377 [TBL] [Abstract][Full Text] [Related]
54. Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes. Profit L Core Evid; 2005; 1(2):89-101. PubMed ID: 22500147 [TBL] [Abstract][Full Text] [Related]
55. Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors. Jiang YK J Mol Model; 2010 Jul; 16(7):1239-49. PubMed ID: 20069322 [TBL] [Abstract][Full Text] [Related]
56. The role of incretins in glucose homeostasis and diabetes treatment. Kim W; Egan JM Pharmacol Rev; 2008 Dec; 60(4):470-512. PubMed ID: 19074620 [TBL] [Abstract][Full Text] [Related]
57. Incretin-based therapies in type 2 diabetes mellitus. Chia CW; Egan JM J Clin Endocrinol Metab; 2008 Oct; 93(10):3703-16. PubMed ID: 18628530 [TBL] [Abstract][Full Text] [Related]